Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Lisette Volpe-Gillot"'
Autor:
Agathe Vrillon, Elsa Mhanna, Clément Aveneau, Manon Lebozec, Lina Grosset, Diane Nankam, Fernanda Albuquerque, Raphaelle Razou Feroldi, Barbara Maakaroun, Iana Pissareva, Dalenda Cherni Gherissi, Julien Azuar, Véronique François, Claire Hourrègue, Julien Dumurgier, Lisette Volpe-Gillot, Claire Paquet
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-8 (2021)
Abstract Background There is limited evidence on the characteristics and outcome of patients with dementia hospitalised for novel coronavirus infection (COVID-19). Method We conducted a prospective study in 2 gerontologic COVID units in Paris, France
Externí odkaz:
https://doaj.org/article/e9e64243a58e4cb0af11d3a58f188574
Autor:
Clara Sanches, Richard Levy, Sarah Benisty, Lisette Volpe-Gillot, Marie-Odile Habert, Aurelie Kas, Sébastian Ströer, Nadya Pyatigorskaya, Anna Kaglik, Angelina Bourbon, Bruno Dubois, Raffaella Migliaccio, Antoni Valero-Cabré, Marc Teichmann
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-15 (2019)
Abstract Background Semantic dementia is a neurodegenerative disease that primarily affects the left anterior temporal lobe, resulting in a gradual loss of conceptual knowledge. There is currently no validated treatment. Transcranial stimulation has
Externí odkaz:
https://doaj.org/article/106bc62b3e4f47db83990853ee891258
Autor:
Yaohua Chen, Thibaud Lebouvier, Emilie Skrobala, Lisette Volpe‐Gillot, Dominique Huvent‐Grelle, Nathalie Jourdan, Mélanie Leroy, Florence Richard, Florence Pasquier, and the Meotis network
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Memory clinics (MCs) are the main model for dementia diagnosis and care. Following the development of a MC network in Northern France, our objectives were to assess its impact on patient characteristics over 20 years. Methods Th
Externí odkaz:
https://doaj.org/article/220b8cdcbffc47c4a9c265a2c176e796
Autor:
Bruno Dubois, Angelina Bourbon, Raffaella Migliaccio, Lisette Volpe-Gillot, Marc Teichmann, Sébastian Ströer, Clara Sanches, Richard Levy, Antoni Valero-Cabré, Sarah Benisty, Aurélie Kas, Nadya Pyatigorskaya, Marie-Odile Habert, Anna Kaglik
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-15 (2019)
Trials
Trials, BioMed Central, 2019, 20 (1), pp.632. ⟨10.1186/s13063-019-3613-z⟩
Trials, 2019, 20 (1), pp.632. ⟨10.1186/s13063-019-3613-z⟩
Trials, BioMed Central, 2019, ⟨10.1186/s13063-019-3613-z⟩
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
Trials
Trials, BioMed Central, 2019, 20 (1), pp.632. ⟨10.1186/s13063-019-3613-z⟩
Trials, 2019, 20 (1), pp.632. ⟨10.1186/s13063-019-3613-z⟩
Trials, BioMed Central, 2019, ⟨10.1186/s13063-019-3613-z⟩
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
Background Semantic dementia is a neurodegenerative disease that primarily affects the left anterior temporal lobe, resulting in a gradual loss of conceptual knowledge. There is currently no validated treatment. Transcranial stimulation has provided
Autor:
Agathe Vrillon, Elsa Mhanna, Clément Aveneau, Manon Lebozec, Lina Grosset, Diane Nankam, Fernanda Albuquerque, Raphaelle Razou Feroldi, Barbara Maakaroun, Iana Pissareva, Dalenda Cherni Gherissi, Julien Azuar, Véronique François, Claire Hourrègue, Julien Dumurgier, Lisette Volpe-Gillot, Claire Paquet
BACKGROUNDThere is limited evidence on the characteristics and outcome of patients with dementia hospitalized for novel coronavirus infection (COVID-19).METHODWe conducted a prospective study in 2 gerontologic Covid Units in Paris, France, from March
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b6352fbc919c7cc17e64aa999247a5
https://doi.org/10.21203/rs.3.rs-208272/v1
https://doi.org/10.21203/rs.3.rs-208272/v1
Autor:
Véronique François, Julien Dumurgier, Elsa Mhanna, Claire Hourregue, Dalenda Cherni Gherissi, Diane Nankam, Fernanda Albuquerque, Lisette Volpe-Gillot, Julien Azuar, Iana Pissareva, Clément Aveneau, Claire Paquet, Raphaelle Razou Feroldi, Lina Grosset, Barbara Maakaroun, Manon Lebozec, Agathe Vrillon
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-8 (2021)
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-8 (2021)
Background There is limited evidence on the characteristics and outcome of patients with dementia hospitalised for novel coronavirus infection (COVID-19). Method We conducted a prospective study in 2 gerontologic COVID units in Paris, France, from Ma
Autor:
Alexis Lepetit, Saidlitz Pascal, Lisette Volpe-Gillot, Florence Lebert, Olivier Drunat, Hermine Lenoir, Pierre Koskas, Samuel Kohler, Maria Soto-Martin, Jean Roche, Mouna Romdhani, Vania Leclercq, Vernaudon Julien
Publikováno v:
International Psychogeriatrics
Autor:
Hugues Chabriat, Siham Dekimeche, Catherine Belin, Julien Dumurgier, Stéphane Goutagny, Lisette Volpe-Gillot, Elodie Bouaziz-Amar, Florence Mahieux, Frank Questel, Bénédicte Defontaines, Emmanuel Cognat, Julien Azuar, Victor Haddad, Jacques Hugon, Antonio Texeira, Pierre-Olivier Sellier, Claire Paquet, Jean-Louis Laplanche
Publikováno v:
Journal of Alzheimer's Disease. 64:889-897
Background CSF Alzheimer's disease (AD) biomarkers allow classifying individuals based on their levels of amyloid and neurodegeneration pathologies. Objective To investigate the distribution of AD biomarker profiles from patients suffering from cogni
Autor:
Elsa Mhanna, Fernanda Albuquerque, Lisette Volpe Gillot, Diane Nankam, Barbara Maakaroun, Agathe Vrillon, Dalenda Cherni Gherissi, Manon Lebozec, Raphaelle Razou Feroldi, Iana Pissareva
Publikováno v:
Revue Neurologique
Introduction Les sujets âges constituent le groupe le plus vulnerable au SARS-Cov2, avec une mortalite elevee. Les troubles neurocognitifs sont une comorbidite frequente chez les patients âges. Neanmoins, les specificites de la COVID-19 chez ces pa
Autor:
Nathalie Sastre, Cécile Adam, Didier Hannequin, Sophie Chauvelier, Marie–Ange Cariot, Hermine Lenoir, Laure Caillard, Djamila Krabchi, Léna Joffredo, Jean-Marc Tréluyer, Olivier Hanon, Françoise Lala, Frédéric Bloch, Bruno Vellas, Stéphanie Bombois, Laurence Hugonot–Diener, Philippe-Henri Robert, Céline Guillemaud, Xavier Delbeuck, Julien Dumurgier, Jean-François Mangin, Nathalie Charasz, Jean-Luc Novella, Vincent Camus, Pierre Anthony, Sylvain Lehmann, Anne-Sophie Rigaud, Audrey Gabelle, Clémence Boully, Lisette Volpe–Gillot, Jacques Touchon, Jacques Boddaert, Vincent Deramecourt, Giovanni Castelnovo, Yasmina Boudali, Marie Chupin, S. Schraen-Maschke, Olivier Guerin, Joël Belmin, Isabelle Saulnier, Valérie Chauviré, Nathalie Schwald, Salim Gherabli, Philippe Robert, Sarah Benisty, Candice Picard, Marie Laurent, Foucaud du Boisgueheneuc, Florien Labourée, Gabiel Abitbol, Sophie Haffen, Patrick Gelé, Hélène Briault, Jean Luc Novella, François Sellal, Claire Gervais, Marie–Agnès Picat, Anne Chawakilian, Marie–Thérèse Rabus, Pierre Jean Ousset, Galdric Orvoen, Thierry Dantoine, Pierre Vandel, Jaques Hugon, Rezki Daheb, Jean-Sébastien Vidal, David Wallon, Diane Dupuy, Karl Mondon, Lisette Volpe-Gillot, Adeline Rollin Sillaire, Christine Delmaire, Frédéric Blanc, Emmanuelle Duron, Anna Kearney–Schwartz, Evelyne Galbrun, Florence Latour, Christine Perret–Guillaume, Florence Moulin, C. Bayle, Sylvie Pariel, Jean-Philippe David, Mohamed Abdellaoui, Stéphanie Libercier, Valérie Gissot, Bernadette Allinquant, Jean-Yves Gaubert, Elena Paillaud, Jean–Marc Michel, Caroline Hommet, Gilles Berrut, Luc Buée, Eliana Alonso, Agnès Devendeville, Anne–Cécile Troussiere, Marie–Anne Mackowiak, Yann Spivac, Jacques Hugon, Pascaline Cassagnaud, Olivier Martinaud, Marion Paulin, Claire Paquet, Matthieu Plichart, Guillaume Sacco, Olivier Godefroy, Sophie Pichierri, Athanase Benetos, M.-L. Seux, Marc Paccalin, Edouard Chaussade
Publikováno v:
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Wiley, 2018, 14 (7), pp.858-868. ⟨10.1016/j.jalz.2018.01.004⟩
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018, 14 (7), pp.858-868. ⟨10.1016/j.jalz.2018.01.004⟩
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Wiley, 2018, 14 (7), pp.858-868. ⟨10.1016/j.jalz.2018.01.004⟩
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018, 14 (7), pp.858-868. ⟨10.1016/j.jalz.2018.01.004⟩
International audience; INTRODUCTION:Diagnostic relevance of plasma amyloid β (Aβ) for Alzheimer's disease (AD) process yields conflicting results. The objective of the study was to assess plasma levels of Aβ42 and Aβ40 in amnestic mild cognitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91fba5d7955f3f3f6137aba6ff96444
https://hal.univ-lorraine.fr/hal-02533144
https://hal.univ-lorraine.fr/hal-02533144